Professor Milica Radisic is featured in a recent CBC News story examining how organ-on-a-chip technologies could transform cancer treatment and drug testing. The article highlights the growing role of lab-engineered human tissues in creating more accurate, patient-specific models for studying disease and predicting how treatments will perform.
The story explores how organ chips—miniature systems that replicate key functions of human organs, including blood flow and tissue movement—are helping researchers move beyond traditional cell cultures and animal testing. Radisic’s work in tissue engineering and organ-on-a-chip platforms reflects the type of innovation driving this shift, underscoring the department’s leadership in advancing personalized medicine and next-generation biomedical research.